The LiveLight™ Liver Carcinoma cell line is a HepG2 model modified to continuously produce luminescence and automatically adjust signal intensity to reflect real-time metabolic activity dynamics.

This line is non-tumor forming and can be utilized for in vitro screening applications.

Cells are suitable for transfection, and cease autonomous luminescence upon death, so they can be multiplexed with destructive, luciferin-dependent assays without signal overlap.